GET THE APP

Anti-cancer Drug Journals | Open Access Journals
Journal of Cancer Clinical Trials

Journal of Cancer Clinical Trials

ISSN: 2577-0535

Open Access

Anti-cancer Drug Journals

Hostile to Cancer Drugs is a global clinical diary, which expects to advance and support research on against malignant growth specialists. It was first distributed in 1990 and it remembers reports for clinical and trial research results, from customary cytotoxic chemotherapy to hormonal or natural reaction modalities.[1] The diary has 10 issues for each year and the momentum manager in boss is MelsSluyser. As per the 2014 Journal Citation Reports, the diary has an effect factor of 1.784, positioning it 164th out of 211 in the class Oncology and 162nd out of 254 in the classification Pharmacology and Pharmacy.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences

Google Scholar citation report
Citations: 95

Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report

Journal of Cancer Clinical Trials peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward